Table 2 Description of physiotherapy intervention
From: Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors
Physiotherapy intervention | All patients N = 23 | Limbs weakness N = 16 | No Limbs weakness N = 7 | P-Value |
|---|---|---|---|---|
Passive Range of motion; n | 132 | 120 | 12 | 0.07 |
Adverse events; n (%) | 0 (0) | 0 (0) | 0 (0) | |
Bed ridden strengthening; n | 8 | 6 | 2 | 0.7 |
Adverse events; n (%) | 0 (0) | 0 (0) | 0 (0) | |
Neuromuscular electrical stimulation; n | 17 | 15 | 2 | 0.78 |
Adverse events; n (%) | 0 (0) | 0 (0) | 0 (0) | |
Inspiratory muscles training; n | 30 | 23 | 7 | 0.6 |
Adverse events; n (%) | 5 (16) | 4 (17) | 1 (14) | |
Verticalization out of bed; n | 28 | 28 | 0 | 0.049 |
Adverse events; n (%) | 0 (0) | 0 (0) | 0 (0) |